Table 1.
Baseline characteristics of the study participants
ACS |
SAP |
Control |
P | |
---|---|---|---|---|
(n = 69) | (n = 85) | (n = 208) | ||
Gender (M:F) |
49:20 |
58:27 |
137:71 |
0.719 |
Age (years) |
62 (54, 71)a |
65 (59, 72)a |
58 (55, 63)b |
<0.001 |
Weight (kg) |
67.6 ± 12.2 |
65.1 ± 10.9 |
64.8 ± 10.5 |
0.175 |
Body mass index (kg/m2) |
24.6 (22.2, 26.7) |
24.2 (22.5, 25.5) |
24.1 (22.3, 26.0) |
0.813 |
Waist circumference (cm) |
87.8 ± 9.0a |
86.4 ± 8.7a |
82.7 ± 8.3b |
<0.001 |
SBP (mmHg) |
118 (106, 126)a |
118 (110, 128)a,b |
122 (111, 133)b |
0.088 |
DBP (mmHg) |
70 (62, 79)a |
71 (64, 76)a |
81 (72, 87.5)a |
<0.001 |
Total cholesterol (mmol/l) |
4.5 (3.5, 5.2)a |
4.0 (3.5, 4.6)a |
5.0 (4.3, 5.7)b |
<0.001 |
LDL-cholesterol (mmol/l) |
3.2 (2.6, 3.5) |
2.9 (2.4, 3.8) |
3.0 (2.4, 3.7) |
0.782 |
Triglyceride (mmol/l) |
1.2 (0.8, 1.8) |
1.3 (0.8, 2.0) |
1.3 (0.9, 1.8) |
0.447 |
HDL-cholesterol (mmol/l) |
1.1 (1.0, 1.3)a |
1.2 (1.0, 1.4)a |
1.4 (1.2, 1.6)b |
<0.001 |
Glucose (mmol/l) |
5.9 (5.4, 6.9)a |
5.9 (5.3, 6.9)a |
5.5 (5.2, 6.0)a |
<0.001 |
Creatinine (mg/dl) |
0.8 (0.6, 0.9)a,b |
0.8 (0.6, 0.8)a |
0.8 (0.7, 0.9)b |
0.065 |
eGFR (mL/min/1.73 m2) |
101.9 (85.1, 118.9)a |
99.7 (85.1, 113.5)a |
92.6 (84.2, 102.8)b |
0.003 |
hsCRP (mg/dl) |
1.3 (0.4, 8.6)a |
0.9 (0.4, 1.3)a |
0.3 (0.1, 0.9)b |
<0.001 |
CTRP-3 (ng/ml) |
329.6 (267.7, 424.1)a |
332.9 (265.9, 407.3)a |
410.6 (330.7, 537.2)b |
<0.001 |
Progranulin (ng/ml) |
173.8 (142.1, 221.6) |
165.6 (138.2, 194.3) |
168.3 (146.4, 209.1) |
0.394 |
Adiponectin (μg/ml) | 7.0 (5.3, 10.3) | 7.1 (5.8, 8.9) | 7.4 (5.3, 10.2) | 0.875 |
Data are expressed as mean ± standard deviation or median (inter-quartile range).
a, b Same letters indicate no statistical significance based on Tukey’s HSD post-hoc test or Wilcoxon’s rank-sum test. ACS, acute coronary syndrome; SAP, stable angina pectoris; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; hsCRP, high-sensitivity C-reactive protein; CTRP-3, C1q/TNF-related Protein-3.